Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Sweden Dermal Bio-Tech AB
AB
Active
Org 5569210965
Dockplatsen 1, 211 19
Malmö
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2013
0 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Sweden Dermal Bio-Tech AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−5
−48
−106
−112
−126
Depreciation & amort.
−0
−5
−5
−5
−5
EBIT
−5
−53
−111
−117
−131
Net financials
1 000
—
1 000
4 000
0
Profit before tax
995
−53
1 052
3 995
−1
Tax
−0
−0
—
—
—
Net profit
995
−53
1 052
3 995
−1
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 301
273
1 223
4 118
3 682
Equity
1 100
48
1 100
4 095
2 094
Long-term debt
0
0
—
—
—
Short-term debt
200
226
122
22
1 587
Total debt
200
226
122
22
1 587
Financial ratios
5-year trend
EBITDA margin
-12629500.0%
This company
15.8%
Market median
-79933644% vs market
2020
2024
Equity ratio
56.9%
This company
38.2%
Market median
+49% vs market
2020
2024
Return on equity
-0.1%
This company
18.4%
Market median
-101% vs market
2020
2024
Net profit margin
-131700.0%
This company
8.1%
Market median
-1626026% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.76×
This company
0.62×
Market median
+23% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Sweden Dermal Bio-Tech AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
